SCN9A
SCN9A (Sodium channel protein type 9 subunit alpha) is a gene. The public catalogues list it as a drug target, and an approved or late-stage drug is recorded against it.
Overview
Pore-forming subunit of Nav1.7, a voltage-gated sodium (Nav) channel that directly mediates the depolarising phase of action potentials in excitable membranes. Navs, also called VGSCs (voltage-gated sodium channels) or VDSCs (voltage-dependent sodium channels), operate by switching between closed and open conformations depending on the voltage difference across the membrane. In the open conformation they allow Na(+) ions to selectively pass through the pore, along their electrochemical gradient.
Open Targets scores its association with cancer at 0.55 (direct and indirect evidence; datatypes literature 0.87, genetic association 0.00, clinical 0.86).
- Target · the protein and the cell it sits on
- Drug · antibody, small molecule, cell or radioligand
- Effect · signal, damage or kill
In plain words · SCN9A (Sodium channel protein type 9 subunit alpha) is a gene. The public catalogues list it as a drug target, and an approved or late-stage drug is recorded against it.
- 1 · What it is
SCN9A (Sodium channel protein type 9 subunit alpha) is a gene. The public catalogues list it as a drug target, and an approved or late-stage drug is recorded against it.
- 2 · What goes wrong in cancer
Pore-forming subunit of Nav1.7, a voltage-gated sodium (Nav) channel that directly mediates the depolarising phase of action potentials in excitable membranes.
- 3 · How drugs use it
No product in this corpus aims at SCN9A yet. Drugs bind the molecule precisely: to switch it off, flag the cell for the immune system, or deliver a payload.
External identifiers
Sources: HGNC HGNC:10597 (approved symbol, name, aliases, locus and cross-references (hgnc_complete_set.txt)); UniProt Q15858 (protein name, function text, keywords and locations (REST API)); Open Targets ENSG00000169432 (association with cancer (MONDO_0004992) 0.55; (GraphQL API, CC0))
Biology
Pore-forming subunit of Nav1.7, a voltage-gated sodium (Nav) channel that directly mediates the depolarising phase of action potentials in excitable membranes. Navs, also called VGSCs (voltage-gated sodium channels) or VDSCs (voltage-dependent sodium channels), operate by switching between closed and open conformations depending on the voltage difference across the membrane. In the open conformation they allow Na(+) ions to selectively pass through the pore, along their electrochemical gradient. The influx of Na(+) ions provokes membrane depolarisation, initiating the propagation of electrical signals throughout cells and tissues. Nav1.7 plays a crucial role in controlling the excitability and action potential propagation from nociceptor neurons, thereby contributing to the sensory perception of pain. Location: Cell membrane; Cell projection, neuron projection; Cell projection, axon (UniProt). Locus 2q24.3 (HGNC).
Notes
top- Written by scripts/fetch-cancer-genes.ts from CIViC, Open Targets, IntOGen, HGNC and UniProt; the function text is UniProt's, condensed and in UK spelling. Roles: Open Targets known-drug datatype score 0.86. Evidence tier "approved-drug" is the strongest of those signals.
- Prevalence not recorded: none of the sources gives a positivity rate.
Latest papers
topQuery for this target: (TITLE:"SCN9A" OR ABSTRACT:"SCN9A" OR TITLE:"sodium voltage-gated channel alpha subunit 9" OR ABSTRACT:"sodium voltage-gated channel alpha subunit 9" OR TITLE:"Sodium channel protein type 9 subunit alpha" OR ABSTRACT:"Sodium channel protein type 9 subunit alpha" OR TITLE:"Nav1.7" OR ABSTRACT:"Nav1.7" OR TITLE:"PN1" OR ABSTRACT:"PN1" OR TITLE:"NE-NA" OR ABSTRACT:"NE-NA") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about SCN9A, not a curated reading list.